Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C018855 |
2-tert-butylhydroquinone |
2-tert-butylhydroquinone results in increased expression of PRKACA mRNA | increases expression | 16014739
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of PRKACA mRNA | decreases expression | 18648102
|
D000242 |
Cyclic AMP |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [[arsenite results in decreased abundance of Cyclic AMP] which results in decreased activity of PRKACA protein] | decreases abundance|decreases activity|decreases reaction | 18309289
|
D000242 |
Cyclic AMP |
[arsenite results in decreased abundance of Cyclic AMP] which results in decreased activity of PRKACA protein | decreases abundance|decreases activity | 18309289
|
C061133 |
Am 80 |
Am 80 results in increased expression of PRKACA mRNA | increases expression | 17229644
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PRKACA mRNA | affects expression | 16483693
|
C015001 |
arsenite |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [[arsenite results in decreased abundance of Cyclic AMP] which results in decreased activity of PRKACA protein] | decreases abundance|decreases activity|decreases reaction | 18309289
|
C015001 |
arsenite |
[arsenite results in decreased abundance of Cyclic AMP] which results in decreased activity of PRKACA protein | decreases abundance|decreases activity | 18309289
|
C015001 |
arsenite |
arsenite results in increased expression of PRKACA mRNA | increases expression | 18191166
|
D001194 |
Asbestos |
Asbestos affects the expression of PRKACA mRNA | affects expression | 17297452
|
C065179 |
atorvastatin |
atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein | increases activity|increases phosphorylation | 19053045
|
C065179 |
atorvastatin |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] | decreases reaction|increases activity|increases phosphorylation | 19053045
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [[arsenite results in decreased abundance of Cyclic AMP] which results in decreased activity of PRKACA protein] | decreases abundance|decreases activity|decreases reaction | 18309289
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA | affects cotreatment|decreases expression | 20360939
|
D002976 |
Clenbuterol |
Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D003024 |
Clozapine |
Clozapine results in increased expression of PRKACA mRNA | increases expression | 15860345
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA | affects cotreatment|decreases expression | 20360939
|
D004280 |
Dobutamine |
Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of PRKACA mRNA | increases expression | 16404146
|
D004365 |
Drugs, Chinese Herbal |
Drugs, Chinese Herbal results in decreased expression of PRKACA protein | decreases expression | 17895526
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PRKACA mRNA | increases expression | 17942748
|
D005576 |
Forskolin |
Forskolin inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of PRKACA mRNA | increases expression | 15860345
|
D016627 |
Oxidopamine |
Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D016627 |
Oxidopamine |
Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D016627 |
Oxidopamine |
Forskolin inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] | decreases phosphorylation|decreases reaction | 16339297
|
D016627 |
Oxidopamine |
Oxidopamine results in decreased phosphorylation of PRKACA protein | decreases phosphorylation | 16339297
|
C057416 |
KT 5720 |
KT 5720 inhibits the reaction [PRKACA protein results in increased phosphorylation of SNAP25 protein] | decreases reaction|increases phosphorylation | 14766180
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] | decreases reaction|increases activity|increases phosphorylation | 19053045
|
D011374 |
Progesterone |
Progesterone results in decreased activity of PRKACA protein | decreases activity | 15456849
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PRKACA mRNA | decreases expression | 12760830
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PRKACA mRNA | increases expression | 16014739
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PRKACA protein | decreases expression | 12760830
|
C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of PRKACA mRNA | increases expression | 16184548
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PRKACA mRNA | increases expression | 15667827 17407152
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.64 | 15322242 14514962 11752688 |
MESH:D000038 |
Abscess |
|
Drugs, Chinese Herbal |
6.10 | 15043669 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.35 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.73 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.21 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.21 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.27 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.27 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.35 | 16434500 19061943 17162532 17620307 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.35 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.49 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.69 | 17306315 16712894 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.85 | 12649775 14617031 16160616 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.34 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.04 | 18759972 |
MESH:D000740 |
Anemia |
|
Drugs, Chinese Herbal |
8.42 | 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.42 | 11748828 |
MESH:D000787 |
Angina Pectoris |
|
Drugs, Chinese Herbal |
5.21 | 11477813 |
MESH:D001004 |
Anus Diseases |
|
Drugs, Chinese Herbal |
5.75 | 15043669 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.54 | 15885639 |
MESH:D015210 |
Arthritis, Gouty |
|
Drugs, Chinese Herbal |
5.55 | 19655406 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
3.70 | 16819260 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
7.23 | 16484594 |
MESH:D050197 |
Atherosclerosis |
|
Asbestos |
7.23 | 18795166 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
4.51 | 14699433 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.76 | 18080171 19368416 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.81 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.49 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
Drugs, Chinese Herbal |
4.63 | 9881647 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.63 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.93 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.93 | 19526202 15136595 16264153 15668708 18628466 16935488 16096432 15567936 18695136 15994142 18234424 16322301 16595493 17369602 15939500 15993339 15692762 16115903 17983394 17426702 18382427 15634643 16826403 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.93 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.60 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.31 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.31 | 18788625 19519916 16878318 18506893 20727157 20084675 3084413 3581430 19107877 20007298 20101231 17428255 16569478 18785209 19383236 18978308 18210153 17978847 10672840 16288022 16681979 16540662 17055752 16807293 17162532 19394651 20214788 19335982 16935385 21159647 20514400 19822196 19701751 11831363 18971187 17173139 19919837 19171122 19418558 17761372 19208518 16698587 18393292 16779866 20432363 20524982 18056438 20935162 10737359 17138121 18494052 16830150 16502159 19052882 18665156 18691550 16328049 19539802 20512989 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.31 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.31 | 17306315 15276417 16507464 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.38 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.22 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.22 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.61 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.61 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
atorvastatin |
6.83 | 18360054 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.83 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.39 | 16109756 17329180 16952015 16651473 16278810 16364871 15811867 16731534 16269455 15476868 15505089 17308081 17351982 16455267 15792986 16242529 17007740 17519947 17924179 17131338 17382496 18627295 17928571 17974986 16612575 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.87 | 17334414 16243910 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.70 | 1977408 15215559 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.39 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.39 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.39 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.74 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.74 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.35 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.35 | 17681005 16919318 11677210 15861022 17110522 16105132 17333356 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.02 | 15668235 16354765 8697196 12621046 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.76 | 17123785 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.55 | 15037631 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
atorvastatin |
4.07 | 16368305 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.65 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.39 | 11575062 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.61 | 12868966 8970840 2524372 11298694 18759878 11906362 8156756 14531868 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.30 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
6.86 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.86 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.86 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.34 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.35 | 9022650 1440618 11289319 16192314 18692083 18289764 18648102 7440962 8291058 9653073 6679447 9328219 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.35 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.35 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Drugs, Chinese Herbal |
11.35 | 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.35 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.60 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.60 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.03 | 16402076 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.20 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.69 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
14.36 | 16819260 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.36 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.36 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.32 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.32 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.32 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.94 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.90 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.06 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.86 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
12.09 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
12.09 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.09 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.81 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.38 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
8.13 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.13 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.47 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.22 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.84 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.39 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.22 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.34 | 17875725 16707910 14766674 16144979 16879835 16495754 16244372 12587719 16244371 18006777 18674790 16330681 17888722 |
MESH:D006333 |
Heart Failure |
|
atorvastatin |
11.52 | 16360360 |
MESH:D006333 |
Heart Failure |
|
Dobutamine |
11.52 | 17440445 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
11.52 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.71 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
9.00 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Drugs, Chinese Herbal |
9.00 | 18339527 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.69 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.90 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.90 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
atorvastatin |
4.89 | 11583720 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.70 | 16046005 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
atorvastatin |
4.99 | 16238680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.73 | 15034207 |
MESH:D006973 |
Hypertension |
|
atorvastatin |
5.37 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.37 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.60 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.27 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.18 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.18 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
atorvastatin |
11.13 | 16908763 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.13 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
11.13 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.13 | 12878042 12200463 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.40 | 10783313 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.81 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.15 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
9.59 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.59 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.59 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.96 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.80 | 6582329 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.94 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Drugs, Chinese Herbal |
3.84 | 15802533 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
8.02 | 16819260 16531727 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.02 | 16766008 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.81 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
10.59 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.59 | 18665156 18407596 20032147 19638242 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Drugs, Chinese Herbal |
10.59 | 17163593 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.07 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
atorvastatin |
4.88 | 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.88 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Drugs, Chinese Herbal |
4.88 | 17881167 12632512 15849816 16610055 17629604 18237412 15641146 15383259 15339415 18606216 15864749 18371158 15763062 18567088 17348192 15744066 17666798 15818738 17036385 15754396 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.88 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.33 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Drugs, Chinese Herbal |
4.33 | 17207593 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.09 | 19426721 19638242 15885732 19642983 19690152 20137499 18977376 12771043 20501860 2862719 18644402 21047994 2422723 19073162 20118626 19812893 19850985 20452335 19294768 19499222 15175105 19427195 20434301 10737359 19551842 20583210 19254457 20492335 18978307 19255062 19090486 9163691 18754104 20405173 20101389 19996281 18648771 16942905 19833225 21167192 21071580 19256749 21278145 12112319 |
MESH:D008113 |
Liver Neoplasms |
|
Drugs, Chinese Herbal |
10.09 | 18339527 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.09 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.09 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
13.05 | 6587162 1399818 598648 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.05 | 18308698 2563599 18282651 17854601 3124819 16267830 16842330 19004024 18544905 19539802 18079962 17174075 18164116 18775883 19126423 19009564 18093689 21159647 17942915 18253720 19519916 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.05 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.05 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Dobutamine |
4.58 | 19353679 |
MESH:D008171 |
Lung Diseases |
|
Dobutamine |
7.48 | 16638327 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.48 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
10.30 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
10.30 | 12111688 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
10.30 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
10.30 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Drugs, Chinese Herbal |
10.30 | 18339527 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.30 | 17077188 16712894 19931552 15276417 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.30 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.31 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.62 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.36 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.43 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Drugs, Chinese Herbal |
9.43 | 14758024 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.43 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.35 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.35 | 19082730 16487513 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.67 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
7.67 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Asbestos |
6.49 | 16564556 18709470 18310086 16919927 16319530 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.49 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.24 | 19142101 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
4.95 | 11304026 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.31 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.58 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
4.38 | 17229644 |
MESH:D009135 |
Muscular Diseases |
|
atorvastatin |
5.26 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.86 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Dobutamine |
8.84 | 12447174 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.84 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.03 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.03 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.03 | 18259882 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.40 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.46 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.20 | 15738583 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.56 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
atorvastatin |
9.39 | 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.39 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.01 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.81 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.81 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.16 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.31 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
8.31 | 18514411 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.90 | 20387270 |
MESH:D009765 |
Obesity |
|
Clozapine |
2.97 | 19142110 18515891 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.24 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.81 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Drugs, Chinese Herbal |
4.79 | 16548355 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.95 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.73 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.73 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.35 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.49 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.28 | 7296757 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
5.25 | 11771942 15893579 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.26 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.94 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.94 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.38 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.98 | 11118676 11222880 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
2.88 | 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.88 | 18437689 15897917 15749863 16729912 16868541 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.88 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.10 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
4.02 | 16819260 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.75 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
8.66 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
8.66 | 11575062 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Drugs, Chinese Herbal |
3.64 | 16987627 |
MESH:D012003 |
Rectal Fistula |
|
Drugs, Chinese Herbal |
5.75 | 15043669 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.01 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.22 | 3692021 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Drugs, Chinese Herbal |
5.06 | 15015336 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.81 | 15625365 17203757 16767912 17710206 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.04 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.58 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.99 | 18806925 17667964 20452607 16141801 20107430 17726453 11763009 20168265 20521326 19369910 18855531 11151749 17123785 20580759 20521320 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.99 | 18513383 1830565 20107430 19369910 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
8.90 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.90 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.90 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.36 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.73 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.07 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.64 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.79 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Drugs, Chinese Herbal |
2.79 | 18339527 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
Drugs, Chinese Herbal |
5.55 | 17634840 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.51 | 20210726 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.42 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.98 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.08 | 3712494 1399818 6587162 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.08 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.08 | 16010429 17909728 |
MESH:D016171 |
Torsades de Pointes |
|
Dobutamine |
5.14 | 19353679 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.89 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
7.89 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.89 | 16712894 11723127 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.58 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.02 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
9.02 | 18645019 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.21 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.35 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.01 | 17678736 17334414 16364871 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.29 | 17502770 20521320 16402076 16141801 20564506 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.87 | 17933447 |
MESH:D014947 |
Wounds and Injuries |
|
Drugs, Chinese Herbal |
4.37 | 16313111 |